IVI Foundation Inc dba Center for … - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2019

Legal Domicile

Principal Officer

Lisa Malecha

Phone

7633702941

Tax Period

2024-01-01 to 2024-12-31

IVI Foundation Inc dba Center for Innovation & Value Research, founded in 2019, is a community nonprofit in the Medical Research sector that reported $2.3M in total revenue in fiscal year 2024. Revenue decreased 20% compared to the prior year. Expenses of $2.9M exceeded revenue, resulting in a 26% operating deficit.

Mission

The Foundation's mission is to advance the science and improve the practice of value assessment in healthcare. The Foundation's goal is to build a platform that facilitates robust and rigorous patient-centered value assessment of health technologies tailored to the needs and interests of individual decision makers.

Program Service Accomplishments

Program 1

Expenses: $1,099,491 Revenue: $259,016

Research Projects - The Foundation develops open-source value models for specific diseases as a laboratory for developing next-generation methods for value assessment.

Program 2

Expenses: $286,551

Stakeholder and patient engagement - Through intentional planning and practice, we seek to ensure patients are full participants and equal partners in our research design, execution, and evaluation.

Program 3

Expenses: $366,970

Media communications - The Foundation collaborates with healthcare stakeholders to engage in research, methods development, and health economic modeling focused on five core areas:1- Developing...

Media communications - The Foundation collaborates with healthcare stakeholders to engage in research, methods development, and health economic modeling focused on five core areas:1- Developing open-source platforms for measuring value2- Building tools to support decision making3- Improving the science of value measurement4- Conducting research to understand and quantify patient perspectives on value5- Engaging research partners for translational and applied use of OSVP models

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $2,012,970

Program Service Revenue $259,016

Investment Income $54,438

Other Revenue $0

TOTAL REVENUE $2,326,424

Expense Breakdown

Grants Paid $0

Salaries & Benefits $1,858,591

Fundraising Expenses $82,237

Program Expenses $2,032,412

Other Expenses $1,079,199

TOTAL EXPENSES $2,937,790

Year-over-Year Comparison

	2024	2023	Change
Revenue	$2,326,424	$2,890,230	-0.2%
Expenses	$2,937,790	$3,196,223	-0.1%
Net Income	$-611,366	$-305,993	+1.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$411,388

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Scott Brunner	Director	1.00	Director	$0	$0	$0
Alan Balch PhD	Director	1.00	Director	$0	$0	$0
Harold Carter PharmD	Director	1.00	Director	$0	$0	$0
Gregory Daniel PhD	Past President	1.00	Officer Director	$0	$0	$0
Neil Weissman	Director	1.00	Director	$0	$0	$0
Patty Fritz	Secretary/Treasurer	1.00	Officer Director	$0	$0	$0
Charles Cutler MD MS	Director	1.00	Director	$0	$0	$0
Vipan Sood MBARPh MRPharmS	Director	1.00	Director	$0	$0	$0
Mark Cziraky PharmD	President	1.00	Director	$0	$0	$0
Suzanne Schrandt	Director	1.00	Director	$0	$0	$0
Adam ThompsonMPH	Director	1.00	Director	$0	$0	$0
Nelly Ganesan	Director	1.00	Director	$0	$0	$0
Kistein Monkhouse MPA	Director	1.00	Director	$0	$0	$0
Lisa Feng drph	Director	1.00	Director	$0	$0	$0
Susan Cantrell	Director	1.00	Director	$0	$0	$0
Jason Spangler	CEO	40.00	Officer	$391,169	$20,219	$411,388
Richard Chapman	Chief Science Officer	40.00	Highest	$279,786	$9,026	$288,812
Tiffany Huth	Chief Communications Offic	40.00	Highest	$224,151	$14,675	$238,826
Erica Malik	Chief Operating Officer	40.00	Highest	$210,000	$6,791	$216,791

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$2,326,424	$2,937,790	$854,448	$-611,366
2023	$2,890,230	$3,196,223	$1,513,807	$-305,993
2022	$2,485,033	$2,810,039	$1,961,316	$-325,006
2021	$1,664,291	$2,258,514	$2,038,987	$-594,223
2020	$3,290,037	$1,680,713	$2,641,128	$1,609,324
2019	$2,434,391	$1,490,241	$1,154,813	$944,150

IVI Foundation Inc dba Center for Innovation & Value Research